American Conference Institute > Intellectual Property > Life Sciences IP Due Diligence

American Conference Institute’s 7th National Conference on

Life Sciences IP Due Diligence

Your Complete Guide to M&As, Licensing, and Other Collaborations for the Pharmaceutical, Biotechnology and Medical Device Industries

Wednesday, January 20 to Thursday, January 21, 2010

Pharmaceutical, Biopharmaceutical, Biotechnology, Medical Device and other Life Science companies

  • Patent and IP Counsel
  • Licensing, Corporate Development, and Business Development Executives
  • General/Corporate Counsel
  • Financial analysts and investment bankers

Patent and IP Attorneys practicing in IP/Life Sciences transactions for the above companies